"From a Whisper to a Roar" is the story of St. Louis native Mellve Shahid who has shown that even in the face of adversity, goodness can prevail. Shahid survived prostate cancer and turned his battle ...
Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment. Here, Dr. Edward Nelson helps outline the key considerations for ...
2. From Shock to Support: How Caregivers Can Help After a Lymphoma Diagnosis Dr. Lauren C. Pinter-Brown UC Irvine Comprehensive Cancer Center Assuming the role of a caregiver when someone you love is ...
Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment. Here, Dr. Krushangi Patel helps outline the key considerations for ...
Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment. Here, Dr. Elizabeth Brem helps outline the key considerations for ...
Living with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma, is about more than treatment cycles and scans. It’s about how you live in the midst of it — equipping ...
CAR T-Cell Therapy is transforming the outlook for people with diffuse large B-cell lymphoma — offering a second chance at remission when standard treatments fail. But, this powerful immune response ...
Dr. Rodrigo C. Leão Edelmuth is a Board Certified Digestive Surgeon at Einstein Hospital Israelita in Sao Paulo, Brazil. Einstein is internationally acclaimed, ranked 22nd best hospital in the world ...
All three CAR T-Cell Therapies that have FDA approval for a relapse of diffuse large B-cell lymphoma—axi-cel, liso-cel, and tisa-cel—share a common goal: reprogramming your own immune system to ...
Isabella Strahan, 21, learned that her beauty isn’t defined by her hair after battling medulloblastoma, an aggressive brain cancer. Following surgery, radiation, and chemotherapy, she now embraces ...
Eight years after surviving neck and throat cancer, two time Academy Award winning actor Michael Douglas, 74, says that dying wasn’t really part of his thought process about his disease. Douglas was ...
CAR T-Cell Therapy has revolutionized treatment for relapsed or refractory diffuse large B-cell lymphoma, offering new hope—but it also comes with serious risks, including a potentially ...